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Chapter 20
Large-Scale Integration of MicroRNA and Gene Expression 
Data for Identification of Enriched MicroRNA–mRNA 
Associations in Biological Systems
Preethi H. Gunaratne, Chad J. Creighton, Michael Watson,  
and Jayantha B. Tennakoon 
Abstract
The discovery of microRNAs (miRNAs) revealed a hidden layer of gene regulation that is able to inte-
grate multiple genes into biologically meaningful networks. A number of computational prediction pro-
grams have been developed to identify putative miRNA targets. Collectively, the miRNAs that have been 
discovered so far have the potential to target over 60% of genes in our genome. A minimum of six con-
secutive nucleotides in the 5¢-seed (nucleotides 2–8) in the miRNA must bind through complimentary 
base pairing to the 3¢-untranslated (3¢-UTRs) of target genes. Given the small sequence match required, 
a given miRNA has the potential to target hundreds of genes and a given mRNA can have 0–50 miRNA 
binding sites. The low-throughput nature of the query design (gene by gene or miRNA by miRNA) and 
a fairly high rate of false positives and negatives uncovered by the limited number of functional studies 
remain as the major limitations. Programs that integrate genome-wide gene and miRNA expression data 
determined by microarray and/or next-generation sequencing (NGS) technologies with the publicly 
available target prediction algorithms are extremely valuable on two fronts. First, they allow the investiga-
tor to fully capitalize on all the data generated to reveal new genes and pathways underlying the biologi-
cal process under study. Second, these programs allow the investigator to lift a small network of genes 
they are currently following into a larger network through the integrative properties of miRNAs. In this 
chapter, we discuss the latest methodologies for determining genome-wide miRNA and gene expression 
changes and three programs (Sigterms, CORNA, and MMIA) that allow the investigator to generate 
short lists of enriched miRNA:target mRNA candidates for large-scale miRNA:target mRNA validation. 
These efforts are essential for determining false positive and negative rates of existing algorithms and 
refining our knowledge on the rules of miRNA–mRNA relationships.
MicroRNAs (miRNAs) are small ~22 nucleotide noncoding 
RNAs that have been predicted to target >60% of the genes in our 
genome to mediate posttranscription gene silencing (1, 2). The 
1.  Introduction
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key determinants for miRNA–mRNA target associations lie in the 
5¢-seed region (nucleotides 2–8) in miRNA and the 3¢-untranslated 
region (3¢-UTR) of mRNA targets (2). The miRNA–mRNA 
target association is catalyzed mainly by the action of Argonaute 
(Ago) family of proteins in the RNA-induced silencing complex 
(RISC) (3). Base pairing of at least six consecutive nucleotides 
within the 5¢-seed of the miRNA with the target site on the 
mRNA is reported to be required at a minimum. However, 
binding can occur through the entire length of the miRNA. 
miRNA–mRNA duplexes that form with perfect or near perfect 
complementarity have been shown to result in mRNA cleavage 
between nucleotides 10 and 11 (4) of the miRNA resulting 
ultimately in mRNA cleavage and decay (4, 5). By contrast, when 
binding occurs through imperfect complementarity, the mRNA 
target is generally kept intact and silencing occurs through trans-
lational repression (6).
With the advent of microarray and next-generation sequenc-
ing (NGS) technologies in the postgenome era, it is now possi-
ble to determine genome-wide miRNA–mRNA associations 
that are significant to specific cellular contexts or systems such as 
the immune system. A number of target prediction algorithms, 
which are primarily based on searches for matches between 
miRNA seed sequences and 3¢-UTRs of genes, have been devel-
oped and freely available (7). Such programs offer users the pos-
sibility of quickly searching for potential targets on a miRNA by 
miRNA basis or potential miRNAs on a gene-by-gene basis. 
However, these approaches are too cumbersome and do not 
offer optimal solutions to integrate the glut of microarray (gene 
and miRNA expression) and sequencing (mRNA-seq and 
miRNA-seq) data that is becoming available on a daily basis. 
More recently, several groups have written programs and soft-
ware packages to address this issue and offer solutions for the 
large-scale three-way integration of gene expression data, 
miRNA expression data and miRNA–mRNA target predictions 
(8). These programs offer the users the possibility of reaping the 
full benefit of these genome-wide studies. It is becoming increas-
ingly clear that miRNAs are very different from the traditional 
transcriptional repressors that we are familiar with. Overexpression 
and loss-of-function studies suggest that most miRNAs have 
only a limited influence on their target genes (approximately 
two- to ten-fold repression) on its own. It appears that the main 
role of miRNAs is to fine-tune gene expression by coordinately 
downregulating multiple genes within and across pathways to 
integrate them into meaningful networks in relation to specific 
cellular states. The question then is what is the impact of global 
shifts in miRNA profiles on the transcriptome and proteome of 
a given cellular state. Furthermore, when aiming to assess the 
role of a given miRNA in relation to a specific biological process, 
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it is essential to consider its impact on all of its targets. 
Consequently, programs that integrate expression data with tar-
get prediction data are vital to understand the role of miRNAs 
in the immune system. In this chapter, we examine in detail 
three programs that allow the large-scale integration of genome-
wide expression and miRNA target prediction data.
While classical northern blotting and quantitative real-time PCR 
continue as techniques used for gene expression studies of single 
or small sets of genes over the past two decades, high-throughput 
microarray-based techniques have been increasingly applied in 
this field to measure several thousands of genes at a time. 
Microarray technology was first described by Schena et al. in 
1995 (9). Over the years, DNA chip based technologies have 
widely demonstrated the power of this high-throughput parallel 
synthesis based method. Microarray DNA chips contain thou-
sands of probes arranged on a regular pattern. Microarrays pro-
duce quantitative gene expression data based on relative dye 
intensities corresponding to DNA hybridized to probes immo-
bilized on chips (10). A typical microarray-based experiment 
consists of preparing a DNA chip based on target DNAs, gener-
ating a hybridization solution containing a mixture of fluores-
cently labeled cDNAs, incubating fluorescently labeled cDNAs 
with DNA chip followed by data detection based on laser tech-
nologies, and finally computer assisted statistical testing and 
data analysis. To disseminate data analyzed by researchers for 
public use, microarray data can be stored in NCBI microarray 
data repository Gene Expression Omnibus (GEO) (http://
www.ncbi.nlm.nih.gov/geo) (11) using a standardized frame-
work, termed microarray markup language (MAML).
MAML employs a standard format to describe microarray 
experiment details, which include experimental design, array 
design, samples, hybridization procedures and parameters, images, 
quantitation, and controls.
Several commercial producers have introduced microarrays with 
different features. The microarrays available in the current market 
differ from one another in terms of the technologies utilized for 
fabrication and their probe design architecture. Some of the popu-
larly known commercial manufacturers are given below:
Affymetrix GeneChip (http://www.affymetrix.com). Affymetrix 
was one of the first microarrays to appear in the market (12). Unlike 
in the case of traditional microarrays where cloning libraries are used 
for probe design, Affymetrix employs an in silico light directed 
synthesizing technology to produce probes on a glass chip (10). 
2.  Materials
2.1. Gene Expression 
Data
2.1.1.  Microarrays
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Bypassing management of clone libraries and ability to synthesize 
highly ordered DNA oligomers in silico are the two distinct advan-
tages of the Affymetrix design.
Agilent (http://www.agilent.com) employs an inkjet-based 
method to print whole cDNA or oligos on chips (13). Chips pro-
duced by Agilent offer 60-mer probes compared to the 25-mer 
probes offered by Affymetrix (10).
Nimblegen (http://www.nimblegen.com/) (14) uses a digi-
tal light processor to synthesize microarrays, apart from their use 
in transcriptome analysis. NimbleGen chips containing specific 
sequences are used to capture large genomic fragments, which 
can be subject to further analysis using Nimblegens GS FLX 
sequencing system (10).
CombiMatrix (http://www.combimatrix.com) offers custom 
arrays generated by a powerful computer-directed semiconductor 
microelectrode based on chip synthesis method, which can be 
programmed to generate a given array of oligonucleotides on 
chips (15). Signal detection can be carried out by either laser 
scanning or electrochemical methods (10).
Illumina bead array (http://www.illumina.com) (16) con-
ventional microarrays are manufactured by spotting oligonucle-
otides on two-dimensional substrates (17). On the contrary, 
Illumina bead based arrays are produced by means of random 
assembly of bead pools on a patterned substrate (17). Illumina’s 
technology offers higher oligo densities on their chips and thus 
higher throughputs by virtue of the intrinsic size of the beads and 
patterned substrates compared to conventional chips.
While array-based technologies and applications continue to 
grow, a plethora of information would be available for researchers 
through GEO in future. This would be a very valuable tool to 
facilitate cross-reference samples, identify signatures associated 
with disease, personalize medicine, and most importantly provide 
a global view of all biological processes through a platform for 
systematic in depth analysis of DNA and RNA variation.
The overall approach of miRNA profiling through microarrays 
remains similar to the approach employed in microarrays for gene 
expression profiling. Mature miRNAs are isolated and purified 
from tissue or cell samples using classical Trizol-based isolation or 
commercially available kits. The purified fragment of RNA is 
enriched and labeled. Array probes are designed by using locked 
nucleic acid (LNA) or chemically modified oligos and spotted on 
microarrays. Hybridization is then carried out and signal intensi-
ties measured using a laser scanner. Finally, quantification and 
data analysis is carried out using computer software. Unlike in the 
case of mRNA arrays designing arrays for miRNAs is challenging 
in that arrays must be designed to discriminate between the 
mature miRNAs and their precursors, miRNA microarrays should 
2.2. miRNA Expression 
Data
2.2.1. MicroRNA 
Microarrays
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be capable of detecting subtle differences of even a single-base 
difference of mature sequences (18). Short sequence length of 
18–25 nt of mature sequences and wide range of melting tem-
peratures (Tm) of mature miRNAs are significant problems in 
miRNA microarray design (19). In spite of the challenges, several 
miRNA microarrays have been designed and are currently avail-
able commercially. Synthetic oligonucleotides or cDNA fragments 
are used in miRNA microarray probe design. More recently, syn-
thetic oligonucleotides with chemical modifications providing 
high molecular affinities facilitating hybridization have been 
employed. AT-rich probes are known to show lesser hybridization 
affinity compared to GC-rich probes (20). Higher degrees of 
sensitivity can be achieved by introduction of A/T analogs, which 
enhance overall duplex stability (21). Substitution of A and T with 
20-O-methyl-2,6-diaminopurine and 20-O-methyl-5-methyluridine, 
respectively, has shown two- to threefold increases in relative 
hybridization (22). LNAs first described by Wengel and coworkers 
in 1998 are a novel class of conformationally restricted oligonu-
cleotide analogs, which show high thermal stabilities toward 
complimentary RNA and DNA (23). Chemically engineered 
LNAs have nucleotide analogs containing a bridging methylene 
group between C4¢ and O2¢ of the ribose ring (24). High thermal 
stabilities of LNAs bound to complimentary nucleic acid facilitates 
the design of short probes with excellent mismatch discrimination. 
Some of the commercially produced miRNA microarrays are 
discussed next.
Agilent miRNA microarrays are produced using unique chemi-
cally unmodified probes. Chemically unmodified oligos are immo-
bilized on an array platform by means of a short stilt, and to the 
5¢ end of the anchored oligo a G residue is included and an 
extended hairpin attached, the 3¢ end of the sample miRNAs are 
labeled by means of a Cy molecule attached to a C residue. When 
sample is introduced, hybridization takes place and the 5¢ G resi-
due of the probe complimentary to the 3¢ Cy labeled C residue 
binds resulting fluorescence. The hairpin functions as a bridge 
connecting the 5¢ end of the anchored oligo and the 3¢ end of the 
hybridized miRNA. Agilent claims that the inclusion of the G 
residue to 5¢ end of the probe increases stability of binding to 
target miRNA and the hairpin destabilizes probe hybridization to 
larger nontarget RNAs and hence provides a higher degree of 
specificity. Agilent’s G44071A human miRNA microarray plat-
form uses sequences from Sanger miRNA database (miRBase) 
version 12 and is capable of detecting unique 866 human and 
89 viral miRNAs. Agilent also produces several arrays in the 
G44 series for human mouse and rat miRNAs, which use differ-
ent versions of the Sanger database ranging from version 9.1 to 
12.0 as the reference source for sequences. In Agilent miRNA 
2.2.1.1. Agilent miRNA 
Microarray (http://www.
home.agilent.com)
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arrays, 40–60 mer unmodified oligonucleotides are directly syn-
thesized on the array by Agilent’s proprietary SurePrint inkjet 
technology. A unique feature of Agilent’s technology is the use of 
end labeling instead of conventional polymerase based methods 
where sample nucleotide damage within the substrate has been an 
issue. End labeling is insensitive to nucleotide damage and is par-
ticularly advantageous when testing preserved or chemically 
treated samples. Agilent’s platform requires only small input 
amounts in the 100 ng range of total RNA due to the high-yield 
end labeling method. As the labeling method does not require 
size fractionation or amplification, undesired bias introduced 
from these two steps is eliminated (25).
Exiqon uses melting temperature (Tm) matched LNA probes in 
their miRNA microarray design. Exiqon’s miRNA microarrays 
are marketed under the name miRCURY LNA™. In addition to 
probes for miRBase sequences, which the Exiqon system uses as 
a reference for their microarrays, Exiqon arrays contain probes 
called mirPLUS™ capture probes, which target proprietary 
miRNAs that have been defined by Exiqon company through 
cloning and sequencing of human normal and diseased tissues. 
Through these proprietary sequence probes, scientists would be 
able to gain unique information about miRNAs, which have not 
been defined elsewhere. As of August 2009 in the Exiqon 
Web site, a typical miRCURY LNA™ was listed as being capable 
of capturing 854 mature human miRNAs, 80 mature viral 
miRNAs, and 428 mature Exiqon-defined human mirPLUS™ 
miRNAs (26).
Invitrogen offers the NCode™ Human miRNA Microarray Kit 
V3 and NCode™ Multi-Species miRNA Microarray Kit V2 as 
integrated miRNA profiling systems, which include reagents for 
RNA isolation labeling and array hybridization. As of the date of 
writing this chapter (30 August 2009), it was listed in the 
Invitrogen Web site that the Human miRNA Microarray Kit V3 
contains probe sequences targeting nearly all of the known human 
miRNAs in the Sanger miRBase as well as probe sequences for 
373 novel putative miRNAs. The Multi-Species version was listed 
as having probes for the Sanger miRBase Sequence Database, 
Release 9.0, for human, mouse, rat, Drosophila melanogaster, 
Caenorhabditis elegans, and Zebrafish. Each NCode™ microarray 
slide comes fully blocked and ready to use. In case where starting 
material has concentrations <500 ng total RNA or equivalent 
cells/tissue, Invitrogen provides a miRNA amplification kit called 
the NCode™ miRNA amplification system. Once the total RNA 
is extracted and ready for hybridization, labeling can be carried 
out using an NCode™. Rapid miRNA labeling system, which is 
2.2.1.2. Exiqon LNA 
Microarrays (http://www.
exiqon.com)
2.2.1.3. Invitrogen (http://
www.invitrogen.com)
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based on a poly-A tailing reaction on RNA molecules followed by 
ligation of dye labeled Alexa Flour™ DNA polymer by means of 
an oligoDT bridge. Invitrogen offers the choices of employing 
either preprinted or self-printed microarrays using NCode™ 
Human or multispecies microarray probes for experiments. 
Analysis of results can be performed by means of NCode™ pro-
filer software. Invitrogen also provides a range of reagents under 
the NCode™ name for verification and further analysis of results 
by qPCR (27).
With the LC Sciences mParaFlo microfluidic miRNA Microarray 
chips assays can be performed with a minimum of 5 mg total 
RNA (28). The mirVana Isolation Kit (Ambion) is recom-
mended. The small RNA (<300 nt) fraction is size fractionated 
with YM-100 Microcon Centrifugal Filter Device (Millipore) 
and 3¢-extended with a poly-A tail by poly-A polymerase. An 
oligonucleotide tag is ligated to the poly-A tail for subsequent 
fluorescent dye staining. This platform allows dual labeling 
using Cy5 and Cy3 tags to label two RNA samples to be com-
pared in dual-sample experiments. Hybridization is performed 
overnight on a mParaFlo microfluidic chip using a microcircula-
tion pump (Atactic Technologies). On the microfluidic chip, 
each detection probe consists of a chemically modified nucle-
otide “coding” segment complementary to target miRNA 
(from miRBase, http://microrna.sanger.ac.uk/sequences/) or 
other RNA (control or customer defined sequences) and a 
spacer segment of polyethylene glycol to extend the “coding” 
segment away from the substrate surface. The detection probes 
are synthesized in situ with photogenerated reagent (PGR) 
chemistry on a Digital Light Projector (Texas Instruments) 
based synthesis system (29). Flexible DNA chip synthesis is 
gated by deprotection using solution photogenerated acids. 
The hybridization melting temperatures are balanced by adjust-
ing length and chemical modifications of the detection probes 
(29). Hybridization is carried out in 100 mL 6× SSPE buffer 
(0.90 M NaCl, 60 mM Na2HPO4, 6 mM EDTA, pH 6.8) con-
taining 25% formamide at 34°C followed by a stringent wash at 
52°C. Hybridization images are collected with a laser scanner 
(GenePix 4000B, Molecular Device) and signal intensity val-
ues extracted using ArrayPro image processing software 
(MediaCybernetics). Data analysis is carried out by first sub-
tracting the background and then normalizing with a cyclic 
LOWESS filter (locally weighted regression). For two-color 
experiments, the ratio of two sets of detected signals (log2 
transformed and balanced) and p-values of the t-test are calcu-
lated; a p-value of less than 0.01 is used to select significantly 
differentially detected signal. Data classification is accomplished 
2.2.1.4. LC Sciences 
(http://www.lcsciences.
com)
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by hierarchical clustering based on average linkage and 
Euclidean distance metric, and visualized with TIGR’s Multiple 
Experimental Viewer (MeV) (30).
Quantile normalization on the channel values is used to 
normalize two-color data within each chip to make single channel 
values within and between arrays more comparable and to improve 
the multiarray data analysis. The single channel normalized values 
are used in subsequent data analysis. Construction of a dendrogram 
on the single channel values, both before and after normalization, 
is recommended to examine the effect of normalization on the 
treatment differences.
Completion of the human reference genome by the international 
human genome sequencing consortium and US-based Celera 
genomics was a cornerstone of human scientific endeavor. This 
achievement clearly paved way for a new exciting era of scientific 
research. The human genome sequencing project commenced in 
the year 1990; by 2000 a draft version of the human genome was 
made available and a completed version was released in the year 
2003. During the human genome sequencing project era, the 
two widely used technologies were the original enzymatic dide-
oxy sequencing method pioneered by Fred Sanger and colleagues 
(31) and the Maxam and Gilbert method, which was described 
during the same year (32). The chemical degradation based 
Maxam and Gilbert method was particularly used in cases that 
were not easily resolved by the popular Sanger technique (33). 
As the human genome project progressed, the need for fast 
automated sequencers became imminent and companies with 
commercial interests were quick to step in to make improvements 
to the Sanger-based technique. In spite of the advances made in 
the Sanger technique through introduction of automated capil-
lary sequencers, particularly the sample preparation steps, which 
involved cloning of sequences into bacterial artificial chromosomes 
(BACs) or yeast artificial chromosomes (YACs) and artifacts 
related to sample preparation remained obstacles of making 
Sanger-based sequencing a completely automatable high-throughput 
method. In view of this fact, several companies came up with 
novel sequencing technologies, which had massively parallel 
high-throughput capabilities enabling genome-scale analysis in a 
relatively short period of time. These sequencing technologies are 
termed NGS technologies. As of today, three platforms, namely 
Roche Applied Science 454 platform, the Illumina platform, and 
Applied Biosystems ABI SOLiD system are widely used in research 
laboratories. More recently, the Helicos single-molecule sequencing 
device, HeliScope was released to the market. A brief description 
of the 454, Illumina and SOLiD systems are given in the following 
paragraphs.
2.2.2. mRNA-seq: 
Next-Generation 
Sequencing
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The 454 FLX pyrosequencer, which was released in 2004, was 
the first to be introduced to the market as an NGS (34). In 
pyrosequencing, each time a nucleotide gets incorporated to the 
nucleotide chain through a polymerizing reaction, pyrophosphate 
is released, and the released pyrophosphate leads to a series of 
downstream events, which results in the production of firefly 
luciferase (35). In the 454 system, DNA fragments are ligated 
with special adapters. One of the adapters facilitates binding of 
the DNA molecule to a bead. Beads containing single DNA frag-
ments are subject to emulsion PCR and followed by a denatur-
ation step. Initial amplification of sample DNA is necessary to 
generate sufficient signal strength in the sequence by synthesis 
step, which is subsequently carried out on beads containing cop-
ies of a given fragment immobilized on an optical fiber chip. In 
the 454 setup, each bead with its amplified fragment is individu-
ally addressable by a CCD camera at the fluorescence detection 
stage. In the sequence by synthesis stage, polymerase enzyme, 
primers, and a given labeled nucleotide of known identity are 
provided to each bead at a time, and the resultant fluorescence 
due to the pyrosequencing reaction is measured via the optical 
fibers equipped to a smart camera. By introducing labeled nucle-
otides of a given kind at each subsequent cycle of the polymerizing 
reaction, the nucleotides being incorporated to the growing 
fragment in each cycle can be detected by fluorescence measure-
ment, and the sequence of each fragment can be decoded and 
assembled using sophisticated computer software. The 454 system 
is capable of detecting sequences in the 400–500 bp range and 
generates around 100 MB of data in a single run. A newer 
improved version of the 454 FLX called Titanium would provide 
a data output of around 500 MB. High costs of operation and 
generally low reading accuracy in homopolar stretches have been 
cited as drawbacks of the 454 system (33).
The Solexa sequencers were first introduced to the market in the 
year 2006 (36) and Illumina acquired Solexa in the year 2007 
(33). The Solexa system is based on sequencing by synthesis 
method, which uses a technology called “Reversible termina-
tion”. The basic workflow of the Illumina platform involves five 
main stages. The initial step involves randomly fragmenting DNA 
and ligating adaptors to random fragments. The second step 
involves attaching DNA to a special glass slide and is followed by 
a third step, where solid-phase bridge amplification is carried out 
using unlabelled nucleotides. The fourth step involves denaturing 
amplified double-stranded DNA on the slide, and finally the fifth 
step involves carrying out a PCR using labeled nucleotides and 
photographing.
Unlike in the case of the 454 instrument where a single vari-
ety of nucleotide is incorporated in each cycle of the fluorescence 
2.2.2.1. The 454 
GenomeSequencer FLX 
Instrument (Roche Applied 
Science) (http://www.454.
com/)
2.2.2.2. The Illumina 
(Solexa) Genome Analyzer 
(http://www.illumina.com/)
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generating polymerizing step, the Illumina instrument introduces 
all four labeled nucleotides to the polymerizing reaction at once. 
However, due to a chemical modification of the nucleotides, each 
time a nucleotide gets incorporated into the growing DNA chain 
termination of polymerization occurs. At this stage, a smart CCD 
camera photographs fluorescence signals resulting from nucleotides, 
which got incorporated to each individually addressable amplified 
cluster of DNA fragments, which are generated at the bridge 
amplification stage. Once photographing of all clusters is com-
pleted, termination is reversed and another set of nucleotides are 
introduced, and once incorporation takes place, the reaction is 
terminated and clusters are photographed. Eventually all photo-
graphic data are analyzed and the sequences are assembled using 
computer software. The sequence read length achieved by this 
technology is around 35 bp, and an advantage of this system is its 
ability to generate huge amounts of data in a single run. The 
Illumina GA2 sequencers released in 2008 had the ability to 
generate around 1.5 GB of data in a single read setup and around 
3.0 GB of data using a paired run. The ability of the instrument 
to generate massive amounts of data having short sequence 
lengths has made this instrument particularly well suited for small 
RNA based research, which generally does not demand long 
sequence reads. With various modifications in sample preparation 
and the use of different reagents, the Illumina platform can be 
used in a versatile fashion for ChipSeq and Bisulfite sequencing 
experiments as well.
In contrast to the polymerase reactions used in 454 and Illumina 
methods, the Applied Biosystems SOLiD technology uses a liga-
tion-based reaction to incorporate fluorescent-labeled nucleotides 
in the sequencing step (37). However, the Solid system shares 
similarities with 454 and Illumina as it utilizes an adapter ligated 
library and emulsion PCR on magnetic beads at the sample prep-
aration stages. The overall work flow of the solid system can be 
summarized as follows. Initially, an emulsion PCR step is carried 
out on adapter ligated DNA fragments anchored to magnetic 
beads to provide sufficient fluorescence intensities during the 
detection step. The magnetic beads containing the amplified frag-
ments are then transferred to a flow cell slide where a ligation 
reaction is carried out. The ligation reaction uses a primer, which 
attaches to the 5¢ prime end of the adaptor that immobilizes DNA 
fragments on the magnetic bead. DNA ligase and specific 8 mers 
whose fourth and fifth bases are specifically encoded with attached 
fluorescent labels are introduced to the reaction. Fluorescent 
detection is followed after each extending ligation step. After liga-
tion and detection, a regeneration step in which the 8 mers 
including the fluorescent labels are removed is carried out and a 
primer corresponding to a single base displacement (n−1) from 
2.2.2.3. The Applied 
Biosystems ABI SOLiD 
System (http://www3.
appliedbiosystems.com/)
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the 3¢ end of the adapter attaching the DNA fragment is intro-
duced, and the ligation cycle is followed while the two encoded 
bases are read. Similar cycles are carried out starting with primers, 
which correspond to n−2, n−3, n−4, and n−5. In each cycle, the 
encoded two bases are interrogated and data stored. Finally, when 
all rounds of ligation have been completed, a computer builds the 
sequence by decoding the stored data as two base pair calls. A 
distinct advantage of this system is the use of two base pair encoding. 
As a result of two base pair encoding, it is possible to discriminate 
between base calling errors, true polymorphisms and single base 
deletions of the sequence by alignment against a high quality ref-
erence. The sequence length in the solid systems is defined in 
between 25 and 35 by the user. A sequencing run in a SOLiD 
system can yield 2–4 GB of DNA sequence data (35).
Information regarding the HeliScope instrument is available at 
http://www.helicosbio.com/ (38). There are also several other 
companies, which are in the process of manufacturing single- 
molecule based powerful sequencers employing state-of-the-art 
technologies. The following links provide information regarding 
these systems, which are either in the developmental phase or are 
ready to step into the market: VisiGen Biotechnologies (http://visi-
genbio.com/) (39), Pacific Biosciences (http://www.pacificbiosci-
ences.com/index.php) (40), Sequenom (http://www.sequenom.
com) (41), Oxford Nanopore Technologies, UK (http://www.
nanoporetech.com/) (42), BioNanomatrix (http://bionanomatrix.
com/) (43), and Complete Genomics company (http://www.
completegenomics.com/) (44).
The small RNA fraction is prepared for Illumina sequencing by 
the ligation of 5¢ and 3¢ RNA adapters according to Illumina’s 
small RNA protocol, which can be found in the link http://www.
illumina.com/downloads/rnaDGESmallRNA_Datasheet.pdf 
(45). Illumina’s small RNA adaptors are ligated to the 5¢ and 3¢ 
ends of size selected <30 nt RNA. Adapter-modified DNA frag-
ments will be enriched by PCR and further gel purified prior to 
sequencing. Small RNA sequencing for each sample is then per-
formed using the Illumina Genome Analyzer (GA-2) according 
to the manufacturer’s small RNA protocol. Typically, this proto-
col results in over 5–10 million small RNA sequence reads per 
sample per lane.
A number of high-throughput computational pipeline have been 
developed for analyzing small RNA sequence reads generated 
by NGS technologies including Illumina sequencing (46). Our 
pipeline is described in (46, 47). For each sample, all unique 
sequence reads with a minimum read count of 10 are aligned to a 
reference set of miRNAs. The reference set is adaptable and cur-
rently consists of the 678 human and 472 mouse mature miRNA 
2.2.2.4. Small RNA 
Sequencing
2.2.2.5. Bioinformatics 
Platform for Analyzing 
Small RNA Sequence 
Reads
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sequences found in the miRNA database (miRBase version 11.0) 
plus 227 miRNA predictions from Berezikov et al. (48). It has 
been observed that the flexibility of DICER processing of the 
precursor miRNA produces a variety of sequence fragments, 
which may be active (49). To account for this, we perform a local 
Smith–Waterman alignment of each unique sequence read against 
each of the mature miRNAs in the reference, allowing for a 3-base 
overhang on the 5¢ end and a 6-base overhang on the 3¢ end. The 
alignments are scored such that a matching or overhanging base 
counts as two points and mismatches as −1. Each unique sequence 
read, which achieves a per-base alignment score of 2 (i.e., a per-
fect match) is associated with each mature miRNA for which it 
achieved that score. The read counts of all redundantly aligning 
reads are equally apportioned to all mature miRNAs to which 
they align.
Each specimen is expected to generate multiple sequences that 
are not sufficiently similar to any known human miRNA. For 
this purpose, a number of algorithms have been developed to 
evaluate the likelihood that the unique sequence that does not 
align with a known miRNA is a putative novel miRNA. Our 
novel miRNA discovery pipeline is described in Creighton et al. 
(8, 47). First, all small RNA sequences that do not align with 
known miRNA precursors are mapped to the reference genome 
sequence of the species the small RNA is derived from (i.e., 
human, mouse, etc.). Each exact sequence match is fetched 
along with 100 bases flanking either side. These ~220-bp 
sequences are then tested for miRNA-like hairpin structure. The 
~220-bp putative precursor sequences are evaluated with the 
Vienna package (www.tbi.univie.ac.at/RNA/) (50). Each of 
the unique sequences that map to a larger hairpin structures is 
tested for the Ambros criteria, which states that “authentic” 
miRNA sequences must map to one arm of a single-loop hairpin 
with a minimum free energy less than −25 kcal/mol (51, 52). 
Hairpins with overly large or unbalanced loops and unique 
sequences that map to the loop of the hairpin are rejected. After 
folding the read plus flanking sequence, the sequence is trimmed 
down to include only the plausible precursor and then folded 
again to ensure that the precursor was not artificially stabilized 
by neighboring sequence. Sequences appropriately placed in 
miRNA-like hairpins are considered to be “putative mature 
miRNAs” (pmms). Strong conservation of the mature miRNA, 
significant (but possibly weaker) conservation of the hairpin arm 
opposite the mature miRNA, and little or no conservation of the 
hairpin loop are considered a positive sign. Poorly conserved 
sequences are also considered since not all known miRNAs are 
conserved. If both the mature miRNA sequence and the miRNA-star 
sequence are found among the sequences, this candidate is 
2.2.2.6. Identification 
of Novel MicroRNAs
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considered a definitive confirmed novel miRNA. If there is a 
substantial difference in abundance, the more abundant form is 
defined to be the mature miRNA and the less abundant form 
the miRNA-star sequence.
miRNA:mRNA target predictions for a number of different 
species are now available in public Web sites. We recommend 
the PicTar algorithm (http://pictar.bio.nyu.edu) (53), which 
uses predictions from Krek et al. (54); TargetScan algorithm 
(http://www.targetscan.org) (55), which uses predictions from 
Lewis et al. (56); and the miRanda algorithm (http://www.
microrna.org) (57). The Sigterms software currently uses all 
three algorithms, and CORNA software is adapted for miRanda 
predictions (58).
Currently available algorithms are diverse, both in approach 
and in performance and all have room for improvement (7). A 
comparative description of some of the better known algorithms 
and their features are given below.
TargetScan provides target predictions for mammalian/verte-
brates offering predictions with site conservation consideration as 
well as without site conservation consideration (55). In predict-
ing targets, the algorithm takes into account parameters such as 
stringent seed pairing, site number and factors influencing site 
accessibility. In the mode where site conservation is taken into 
account, there is an option to rank by preferential conservation 
instead of site context (7).
PicTar provides target predictions for a wider variety of clades 
including mammalian/vertebrate, fly, and worm (53). The factors 
taken into consideration in this algorithm are stringent seed pairing 
for at least one of the sites of the miRNA, site number, and overall 
pairing stability (59). PicTar takes into consideration site conserva-
tion for all cases and does not offer a feature where target predic-
tions can be done without taking conservation into account (7).
The miRanda algorithm is capable of making miRNA target pre-
dictions for mammal/vertebrate, fly, worm as well as additional 
species (56). In its criteria for target prediction, the algorithm 
takes into account site number, pairing to most of the miRNA, 
and moderately stringent seed paring (60).
The PITA algorithm is capable of predicting miRNA–mRNA 
targets for mammalian/vertebrate, fly, and worm clades with site 
conservation consideration as well as without site conservation 
consideration (61). In its model for target predictions, PITA uses 
predicted site accessibility and stability as well as moderately 
stringent base paring and the number of sites (62).
2.3. miRNA Target 
Prediction Programs
2.3.1. TargetScan (http://
www.targetscan.org/)
2.3.2. PicTar (http://pictar.
mdc-berlin.de/)
2.3.3. miRanda (http://
www.microrna.org)
2.3.4. PITA (http://genie.
weizmann.ac.il/pubs/
mir07/mir07_prediction.
html)
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Methods and software for integrating gene expression results 
with miRNA expression can help to maximally assess the role of 
miRNAs as integrators of genes into biologically meaningful 
networks. This is based on the fact that a given miRNA typically 
has predicted target sites in the 3¢-UTRs of hundreds of genes 
and a given mRNA has multiple binding sites for several differ-
ent miRNAs. In addition, genes that belong to specific pathways 
or networks are coordinately regulated. For all these reasons, it 
is essential that miRNA–mRNA association analyses are dealt 
with in the context of genome-wide changes in transcripts. The 
ultimate aim is to determine predicted miRNA–mRNA pairs 
that are correlated in expression in the context of a specific 
experiment. These could be the genes which are significantly 
differentially expressed when comparing two different biologi-
cal states or genes that remain correlated in a treatment time 
course.
Current insight suggests that miRNAs exert their biologic 
effects by posttranscriptionally targeting gene expression; it fol-
lows that low expression of a given miRNA in a given system 
should conceivably cause a concomitant reversal of expression 
patterns for in silico predicted gene targets. Given this, we could 
define a miRNA–mRNA functional pair as consisting of a miRNA 
being predicted to interact with a given mRNA, where the two 
are also anticorrelated with each other in terms of expression. 
Public gene targeting prediction databases usually provide Web 
interface, where the user can look up predicted miRNA–mRNA 
functional pairs for a specific miRNA or gene of interest. In cases 
where the number of genes of interest (e.g., a set of genes arising 
from an expression profiling experiment) is in the hundreds, a 
gene-by-gene approach to looking up miRNA–mRNA pairs 
becomes impractical. Below we describe public software tools 
designed to make the task of integrating lists of genes and 
miRNAs easier.
CORNA (63) is an open-source package for the free statistical 
software R (http://www.r-project.org) (64) and allows scientists 
to analyze gene lists in the context of miRNA target predictions. 
In particular, when a list of genes and a list of miRNA target 
predictions are given, CORNA will carry out enrichment analysis 
to determine whether the gene list is enriched for particular 
miRNA targets more than that can be expected by chance. For 
example, the input gene list can come from a significant gene list 
from a microarray experiment or a biological pathway. Further 
methods within CORNA exist to test for significant associations 
3. Methods
3.1. CORNA (http://
corna.sf.net)
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between miRNAs, pathways, and gene ontology (GO) terms and 
to display quantitative data associated with miRNA targets. 
CORNA employs three complementary statistical methods for 
enrichments analysis of relationships within lists of genes: the 
HyperGeometric test, Fisher’s exact test, and the c2-test. Central 
to the flow of information through CORNA is the gene list, from 
which the user may test for significant miRNA target associa-
tions. The user may also start with a miRNA, find genes that are 
targeted by that miRNA, and then test that gene list for enrich-
ment of KEGG pathways or GO terms. The user may also plot 
quantitative data associated with the targets of a particular 
miRNA. CORNA exclusively uses R vectors and data frames and 
includes functions for reading miRNA target data directly from 
miRBase (65) and microRNA.org (60). There are also helper 
functions to read gene and GO term data using biomaRt (66); 
microarray data directly from GEO (67); and pathway data 
directly from KEGG (68). A comprehensive tutorial exists at 
http://corna.sf.net.
Like CORNA, the Sigterms package allows the user to obtain 
miRNA–mRNA relationships for an entire set of genes (69). While 
CORNA runs with R, Sigterms consists of a set of Excel macros. 
The user enters a set of selected genes into an Excel “Annotation” 
workbook, which represents the entire set of genes on the gene 
profiling platform. The Annotation workbook can contain miRNA 
target predictions from one of the three commonly used algo-
rithms (TargetScan, PicTar, and miRanda), as well GO annotation 
or other pathway information. Annotation workbooks for a given 
gene array platform representing human or mouse genes can be 
found at http://sigterms.sourceforge.net.
The user-provided list of genes is first entered into a 
Microsoft Excel document. The software will then look up the 
genes in the Annotation workbook to retrieve all miRNA–mRNA 
pairs for the given algorithm. For each miRNA, Sigterms com-
putes an enrichment statistic that determines if the set of genes 
that are differentially expressed in the context of an experiment 
have binding sites more than expected by chance for that par-
ticular miRNA. Sigterms outputs the entire set of miRNA–mRNA 
pairs into an Excel worksheet; the user can then filter this work-
sheet for the miRNAs of interest (e.g., those miRNAs that are 
anticorrelated in expression with the genes). For computing the 
one-sided Fisher’s exact tests for enrichment of a set of targets 
for a particular miRNA within the set of genes, the reference 
gene set determined by the complete probe set on a given array 
is used. To account for multiple testing of miRNAs, Monte 
Carlo simulation testing is performed using a 100 randomly 
generated gene sets. For a given gene set and a given target 
3.2. Sigterms  
(http://sigterms.
sourceforge.net)
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prediction database, the number of miRNAs having a nominal 
significant p-value (p < 0.05) for target enrichment is computed 
for each of the 100 random tests. To calculate FDR, the average 
number of miRNA associations less than or equal to the given 
nominal p-value for the 100 random tests is used. The ultimate 
goal is to identify predicted targets within the gene set, that are 
enriched or overrepresented, which could help to implicate roles 
for specific miRNAs and miRNA-regulated genes in the system 
under study.
MMIA (which stands for “MicroRNA and mRNA integrated anal-
ysis”) is a Web-based application meant to provide a “one-stop” 
combined analysis of the miRNA/mRNA input data for various 
pathway-associated gene sets (70). The user inputs mRNA expres-
sion data as a tab-delimited text file along with either a miRNA 
expression data table or a list of top expressed miRNAs. Given the 
user-defined statistical cutoff values, MMIA defines the differen-
tially expressed genes and miRNAs from the data. Using miRNA 
prediction algorithms (TargetScan, PITA, and PicTar), MMIA 
then matches the upregulated or overexpressed genes with the 
downregulated or underexpressed miRNAs, and vice versa. MMIA 
can also generate heat maps of the data and search mRNA–miRNA 
pairs for pathway-related gene set enrichment. The MMIA software 
offers a convenient way for users to upload and analyze their data, 
though less flexible in how the analysis is carried out, as compared 
to CORNA or Sigterms.
Programs such as CORNA, Sigterms, and MMIA provide 
investigators without substantial bioinformatics support means 
by which they could make optimal use of their gene and miRNA 
expression data. The aim is to generate a list of miRNA–mRNA 
associations that are significantly correlated in the experiment 
of interest. The goal is to provide short lists of miRNA–mRNA 
pairs to be validated by direct biochemical assays, which establish 
that the miRNA–mRNA pair occurs in a duplex and coimmu-
noprecipitates in Argonaute complexes (71) and functional 
assays that demonstrate that the 3¢-UTR of the mRNA is 
responsive to the cognate miRNA in luciferase or GFP reporter 
systems (72).
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